Jacobs Neurological Institute

Buffalo, New York 14203

0 studies enrolling now · 7 studies all time

What they study most

Acute Brainstem/Cerebellar Syndrome, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis, Pseudobulbar Affect (PBA), Transverse Myelitis

Studies at this site

• Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis — Completed
• Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis — Completed
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS — Completed
• Natalizumab Temporary Discontinuation Study — Completed
• Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study — Completed